Parminder K. Judge, PhD, explains why eGFR and electrolytes should be monitored when diuretics are added to reach intensive BP targets in patients with CKD
|Videos|June 17, 2014
Clinical Assessment and Principles of Management of Psoriatic Arthritis
Philip Mease, MD, director of rheumatology research at Swedish Medical Center and clinical professor at the University of Washington School of Medicine in Seattle, discusses key points regarding the diagnosis and treatment of psoriatic arthritis in this video produced by the Cleveland Clinic Center for Continuing education.
Advertisement
Philip Mease, MD, director of rheumatology research at Swedish Medical Center and clinical professor at the University of Washington School of Medicine in Seattle, discusses key points regarding the diagnosis and treatment of psoriatic arthritis in this video produced by the Cleveland Clinic Center for Continuing education.
Advertisement
Related to this article
The once-daily device, bioequivalent to the existing prefilled syringe, gives adults with AChR antibody-positive generalized MG a second self-injection option.
In an interview with Pharmacy Times, Ali A. Habib, MD, clinical professor of neurology at the University of California, Irvine, discusses what the hospitalization findings mean for patients and why they should be viewed as supportive evidence
Advertisement
Advertisement
Trending on Pharmacy Times
1
Finerenone Expands MRA Options as Pharmacists Address Underrecognized HFpEF
2
Diuretics, eGFR, and Intensive BP Lowering in CKD: What to Watch
3
Finerenone in Heart Failure: Evidence and Practice a Year Later
4
Breast Cancer Treatment Ends, But The Medication Questions Don’t
5